Literature DB >> 25473558

Synchronous diffuse large B-cell lymphoma and squamous cell lung carcinoma.

Masato Fujii1, Toshihiro Shirai1, Kazuhiro Asada1, Yuu Saito2, Masahide Hirose3, Takafumi Suda4.   

Abstract

A 68-year-old woman was referred for a nodule in the right lung and hilar and mediastinal lymphadenopathy. Physical examination revealed left cervical lymphadenopathy. 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) images revealed radiotracer uptake in the pulmonary nodule and multiple lymph nodes of the truncus. Biopsies confirmed the diagnosis of synchronous diffuse large B-cell lymphoma and squamous cell lung carcinoma. Because the etiology of hilar and mediastinal lymphadenopathy was unknown, the staging of lung cancer could not be determined. We performed therapy for malignant lymphoma earlier than lung cancer. After therapy, FDG-PET showed that uptake in the lymph nodes due to lymphoma had disappeared, whereas uptake in the pulmonary nodule and right hilar lymph node remained or had increased. Based on these findings, the staging of lung cancer was determined and radical surgery was performed successfully. This rare case of synchronous malignancy illustrates the limitation of initial single testing of FDG-PET.

Entities:  

Keywords:  18F-fluorodeoxyglucose positron emission tomography; diffuse large B-cell lymphoma; squamous cell lung carcinoma; staging; synchronous

Year:  2014        PMID: 25473558      PMCID: PMC4184728          DOI: 10.1002/rcr2.40

Source DB:  PubMed          Journal:  Respirol Case Rep        ISSN: 2051-3380


  4 in total

1.  Radiographic distribution of intrathoracic disease in previously untreated patients with Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  R Filly; N Bland; R A Castellino
Journal:  Radiology       Date:  1976-08       Impact factor: 11.105

2.  Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.

Authors:  G Jerusalem; Y Beguin; M F Fassotte; F Najjar; P Paulus; P Rigo; G Fillet
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

3.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

4.  Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.

Authors:  Laurie H Sehn; Jane Donaldson; Mukesh Chhanabhai; Catherine Fitzgerald; Karamjit Gill; Richard Klasa; Nicol MacPherson; Susan O'Reilly; John J Spinelli; Judy Sutherland; Kenneth S Wilson; Randy D Gascoyne; Joseph M Connors
Journal:  J Clin Oncol       Date:  2005-06-13       Impact factor: 44.544

  4 in total
  3 in total

1.  Follicular Lymphoma mimicking Metastatic Nodes on the F-18 FDG PET/CT and MRI for Staging of Endometrial Cancer.

Authors:  Seok-Nam Yoon
Journal:  Nucl Med Mol Imaging       Date:  2016-11-05

2.  Response to R-CHOP in HPV-related squamous cell carcinoma of base of tongue: a case report.

Authors:  Ting Martin Ma; Hyunseok Kang; Steven P Rowe; Ana P Kiess
Journal:  Cancers Head Neck       Date:  2018-05-24

Review 3.  Synchronous primary pulmonary adenocarcinoma and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: A case report and literature review.

Authors:  Lixia Sun; Bing Zhang; Ke Xuan; Li Qi; Jingjing Wang; Quan Li; Jianwei Liu; Yubo Wang; Liping Sun; Xiaomei Li; Hong Ji
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.